Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT01171209

Completed

REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients (REPAIR)

Multiple Sclerosis
NCT00676156

Completed

A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis

Multiple Sclerosis
NCT01487096

Completed

Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

Multiple Sclerosis
NCT01281657

Completed

Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program

Multiple Sclerosis
NCT00666224

Completed

Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome (PreCISe)

Multiple Sclerosis
NCT01448252

Completed

T Cell Vaccination in Patients With Progressive Multiple Sclerosis

Multiple Sclerosis
NCT01220830

Unknown

Cytotron® Delivered Rotational Field Quantum Nuclear Magnetic Resonance Therapy for Multiple Sclerosis (RFQMR)

Multiple Sclerosis
NCT01432704

Completed

Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) (100207MS-H)

Multiple Sclerosis
NCT00484536

Terminated

Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

Multiple Sclerosis
NCT01333358

Unknown

Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients (CAMA-2)

Multiple Sclerosis
NCT00537082

Completed

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)

Multiple Sclerosis
NCT00190268

Completed

Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis

Multiple Sclerosis
NCT00525343

Completed

Avonex 15 Year Long Term Follow-up Study (15yASSURANCE)

Multiple Sclerosis
NCT00267319

Completed

FOCUS Fatigue Outcome in Copaxone USers

Multiple Sclerosis
NCT00818103

Unknown

Characteristic Study on Chinese Patients With Multiple Sclerosis

Multiple Sclerosis
NCT00137176

Completed

EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis

Multiple Sclerosis
NCT00276172

Completed

Open-Label Natalizumab Safety Extension Study

Multiple Sclerosis
NCT00364936

Completed

Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)

Multiple Sclerosis
NCT00912860

Completed

Immunogenicity and Safety Study of Serum-Free Avonex

Multiple Sclerosis
NCT00343590

Completed

Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study

Multiple Sclerosis
NCT00146068

Completed

EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis

Multiple Sclerosis
NCT00001781

Completed

Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)

Multiple Sclerosis
NCT00493077

Completed

Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy (SAFE)

Multiple Sclerosis
NCT00473213

Completed

Optimizing IFN Beta - 1B Dose (Optims)

Multiple Sclerosis
NCT00010998

Completed

Yoga: Effect on Attention in Aging & Multiple Sclerosis

Multiple Sclerosis
NCT00010842

Completed

Natural Antioxidants in the Treatment of Multiple Sclerosis

Multiple Sclerosis
NCT07431281

Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Gastric Cancer | Esophageal Cancer | Gastroesophageal Junction Adenocarcinoma
NCT01954745

Completed

Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma

Bile Duct Cancer | Intrahepatic Cholangiocarcinoma | Cholangiocarcinoma of the Extrahepatic Bile Duct
NCT00005067

Terminated

Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer

Recurrent Prostate Cancer | Stage I Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer
NCT01655836

Active, not recruiting

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Recurrent Prostate Cancer | Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer
NCT01949337

Active, not recruiting

Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer
NCT03636256

Completed

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Urologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Cancer | Bladder Cancer | Urothelial Carcinoma | Urologic Cancer | Urinary Bladder Neoplasm | Cancer of the Bladder | Malignant Tumor of the Urinary Bladder
NCT00005958

Unknown

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter
NCT00003105

Completed

Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter
NCT00022191

Completed

Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
NCT00014274

Completed

Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
NCT00080795

Completed

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
NCT00792025

Completed

Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter
NCT06012513

Not yet recruiting

Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis

Sleep Disorder
NCT05330338

Active, not recruiting

Genetics of Ventriculo-arterial Discordance (PreciPed)

Heart Defects, Congenital
NCT04115930

Completed

Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients (PAMS)

Quality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple Sclerosis
NCT03363360

Unknown

Comprehensive Awareness and Control in Diabetes Patients in China Jiangxi: A Cross-Sectional Survey

To Assess the Level of Control of Blood Glucose, Blood Pressure, and Blood Lipids Among Patients With Type 2 Diabetes in Jiangxi Province
NCT06472635

Active, not recruiting

a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study (ANACIIRE-1)

The Neoadjuvant Treatment for Resectable Esophageal Squamous Cell Carcinoma
NCT04910789

Recruiting

Transhiatal/Transabdominal Approach Compare With Thoracoabdominal Approach for Siewert II Adenocarcinoma of Esophagogastric Junction

Adenocarcinoma of Esophagogastric Junction
NCT05480384

Active, not recruiting

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

Esophageal Cancer | Esophageal Adenocarcinoma | HER-2 Protein Overexpression | Gastroesophageal-junction Cancer
NCT06939075

Not yet recruiting

Role of Cross Sectional Imaging Modalities in the Diagnosis and Characterization of Colonic Masses

ROLE OF Cross Sectional Imaging Modalities in the Diagnosis and Characterization of Colonic Masses
NCT05824494

Not yet recruiting

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Cervical Cancer | Uterine Cervical Neoplasms | Cancer of Cervix | Uterine Cervical Cancer | Cervical Neoplasms | Cancer of the Uterine Cervix
NCT03469843

Completed

Characterization of the Cardiac Reinnervation of Patients With Transposition of the Great Arteries Long After Repair With the Arterial Switch Operation. Correlation With Electrocardiographic and Exercise Test Parameters

Congenital Heart Disease | Transposition of the Great Arteries | Congenital Heart Defect
NCT03628079

Terminated

A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin. (RepoMeb)

Cancer of the Gastrointestinal Tract | Cancer of Unknown Origin
NCT00666887

Completed

Minocycline in Clinically Isolated Syndromes (CIS) (MinoCIS)

Clinically Isolated Syndromes | Early Single Relapse of Multiple Sclerosis

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations